GlassScriptPhysician profile
Gilbert L Trout
NPI 1598167033
$3,992.49
in general payments reported to CMS, 2019-2025
30 companies · $684 in 2025
The $684 reported for 2025 was more than what 77% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $413 · 2022: $605 · 2023: $1,403 · 2024: $888 · 2025: $684.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,889 · Education: $85.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,889.32 |
| Education | $85.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| C. R. Bard, INC. & Subsidiaries | $1,116.01 | 2023-2024 | Bard Urinary Drainage Bag |
| Astellas Pharma US INC | $436.06 | 2021-2024 | Xtandi, Myrbetriq |
| 180 Medical, INC. | $396.03 | 2023-2025 | Gentlecath, Gentlecath Glide |
| Rochester Medical Corporation | $360.78 | 2021-2022 | |
| Abbvie INC. | $271.31 | 2021-2024 | |
| Sumitomo Pharma America, INC. | $233.02 | 2023-2025 | Gemtesa, Orgovyx |
| Janssen Biotech, INC. | $199.25 | 2021-2024 | Akeega, Erleada |
| Pfizer INC. | $196.08 | 2021-2025 | |
| Kerecis Limited | $101.91 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Urogen Pharma, INC. | $101.87 | 2021-2024 | Jelmyto |
| Myriad Genetic Laboratories, INC. | $76.93 | 2022-2023 | Prolaris |
| Myovant Sciences INC. | $55.87 | 2021 | |
| Medtronic, INC. | $54.15 | 2022 | |
| Endo Pharmaceuticals INC. | $40.50 | 2023 | Aveed, Xiaflex |
| Sun Pharmaceutical Industries INC. | $31.65 | 2024 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $31.10 | 2023 | Provenge |
| Boston Scientific Corporation | $29.24 | 2022 | |
| Merck Sharp & Dohme LLC | $28.43 | 2023 | Keytruda, Lynparza |
| Progenics Pharmaceuticals, INC. | $27.78 | 2024 | |
| Teleflex LLC | $25.28 | 2025 | Urolift |
| Accord Healthcare, INC. | $24.88 | 2024 | |
| Endo USA, INC. | $23.10 | 2025 | Aveed, Xiaflex |
| Olympus America INC. | $21.79 | 2025 | Itind System |
| Laborie Medical Technologies Corp. | $20.73 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Astrazeneca Pharmaceuticals LP | $19.39 | 2024 | Lynparza |
| Angiodynamics, INC. | $19.15 | 2024 | Nanoknife |
| Novartis Pharmaceuticals Corporation | $17.80 | 2025 | |
| Tolmar, INC. | $15.10 | 2023 | |
| Halozyme INC | $13.48 | 2023 | |
| Travere Therapeutics, INC. | $3.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gilbert Trout listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.